IFNγ/IL-10 ratio was nonetheless found reduced in NSCLC patients compared with the COPD group, supporting the notion that the TH1 response in NSCLC patients was turned down, whereas the TH2 response was more prominent. This evidence concerns the gene IFNG and chronic obstructive pulmonary disease.